<DOC>
	<DOCNO>NCT00857012</DOCNO>
	<brief_summary>Patients eligible inclusion NIS take anastrozole either upfront follow two three year tamoxifen treatment ( `` switch '' ) least three six month prior offer individual participation program . Treatment follow local therapy guideline standard practice . Treatment decision patient participate study include assessment supportive therapy follow-up visit also follow guideline remain independent program .</brief_summary>
	<brief_title>Arimidex : Compliance Arthralgias Clinical Therapy ( COMPACT )</brief_title>
	<detailed_description>The patient population include postmenopausal woman hormone-receptor positive primary breast cancer schedule adjuvant upfront endocrine treatment anastrozole follow two three year tamoxifen treatment ( `` switch '' ) accord current SmPC ( Appendix C ) . Patients take anastrozole least three month six month start study .</detailed_description>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Postmenopausal woman age 18 year old ; Postmenopause define Natural menopause menses &gt; 1 year ago Serum FSH ( &gt; 20 IU/ l ) , E2 level postmenopausal range patient bilateral oophorectomy Histologically / cytologically confirm primary diagnosis early breast cancer ( M0 ) hormone sensitive tumour ( ER+ve and/or PgR+ve ) Patients , underwent breast cancer surgery , appl . radiation therapy and/or neo/adjuvant chemotherapy take adjuvant endocrine treatment anastrozole ( upfront follow two three year tamoxifen ) min 3 max 6 month In case previous therapy tamoxifen ( switchtherapy ) , duration tamoxifen treatment least two three year . Patients severe renal function disorder ( Creatinine clearance &lt; 20 ml/min Patients moderate severe disorder hepatic function Concomitant treatment drug know affect sex hormonal status tamoxifen Patients ductal carcinoma situ ( DCIS ) without primary diagnosis early breast cancer ( M0 ) Evidence significant clinical disorder laboratory find opinion investigator , make undesirable patient participate program</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Primary early MCa</keyword>
	<keyword>Arimidex</keyword>
</DOC>